DrPeter Stacpoole

Combined pharmacologic and AAV gene therapy of pyruvate dehydrogenase deficiency

Metabolism and Mitochondrial Energetics Therapy for Septic Shock

Activating Pyruvate Dehydrogenase Complex to Improve Barth Syndrome Cardiac Function

Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019

Personalized dosing of dichloroacetate for the treatment of rare and common diseases

DCA Kinetics Analysis

The North American Mitochondrial Disease Consortium (NAMDC)

Personalized dosing of dichloroacetate for the treatment of rare and common diseases

Therapeutic use of dichloroacetate in treatment of perinatal mitochondrial deficiency and cardiac dysfunction

Effects of maternal cortisol on perinatal cardiac metabolism and function

Personalized Dosing of Dichloroacetate for the Treatment of Rare and Common Diseases

Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1

Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)

Miscellaneous Donors

RAPID HAPLOTYPING PROCEDURE FOR DETERMINING THE RESPONSE OFPATIENTS TO DCA

NAMDC: Overall Research Plan

Validation of an Observer Reported Outcome (ObsRO) Measure of Home Functionality in Children with Pyruvate Dehydrogenase Complex Deficiency (PDCD)

Revenue for Project Open Label DCA Admin